Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Giessen
• Collaborator: Indonesian Directorate General of Higher Education
• Treatments: Ethambutol; Isoniazid; Pyrazinamide; Rifampin

Criteria

Inclusion Criteria:

• Newly diagnosed adult male and female TB active patients

• Having clinical evidences of active TB symptoms

• Positive or negative sputum smears

• Having positive chest X-ray that compatible with a diagnosis of tuberculosis

• No history of previous anti tuberculosis treatment

• Give a written informed consent and basic contact data

Exclusion Criteria:

• Heavy smoker (> 20 cigarettes per day)

• Pregnancy and lactation

• Extra pulmonary TB

• Known allergy to soybean

• Having clinical evidences of any underlying disease